The Statistics and Health Economics Core of the San Francisco Treatment Research Center provides full and ongoing supports for three central and critical activities ofthe Center;data management, statistical, and economic analysis.
The specific aims are;(1) To provide data management by supplying structure, support, coordination and oversight for the collection, computer entry, and tracking of research data, including the security and integrity of all Center data. (2) To provide methodological consultation and biostatistical analyses for each component. (3) To conduct research into quantitative methods designed to enhance Center-wide research. (4) To assess the cost of innovative treatments and the impact of the innovations on other health care costs incurred, to value treatment outcomes using economic models and to combine these data in cost-effectiveness analyses. The Core will also take the lead on three planned studies of the complexity of types of cigarette smokers, a meta-analysis, and a cross-cutting economic study. By the very nature of our work this Core is intimately tied to the theme of the Center as a key resource for all proposed Center components including the cross-component studies. Research on continuing and complex treatment for complex patients requires the collection, management, and analysis of complex datasets. In concert with the theme we use rigorous methodology, much of it derived from clinical trials, combine efficacy and costeffectiveness analysis, do work that bridges the gap between treatment and services research and analyze relations between multiple risk factors, both as predictors and time dependent covariates. This Core supplies the quantitative activities of all component studies and integrates its work with the Scientific and Administrative Core.

Public Health Relevance

By analyzing the data collected by each ofthe studies of this Center, the component studies are able to achieve their specific aims. In this way, the public health impact of those studies is met through the work of this Core.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1-EXL-T)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Francisco
San Francisco
United States
Zip Code
Weisner, Constance M; Chi, Felicia W; Lu, Yun et al. (2016) Examination of the Effects of an Intervention Aiming to Link Patients Receiving Addiction Treatment With Health Care: The LINKAGE Clinical Trial. JAMA Psychiatry 73:804-14
Guydish, Joseph; Masson, Carmen; Flentje, Annesa et al. (2016) Scientific writing seminar for early-stage investigators in substance abuse research. Subst Abus 37:238-41
Trager, Evan; Khalili, Mandana; Masson, Carmen L et al. (2016) Hepatitis C Screening Rate Among Underserved Adults With Serious Mental Illness Receiving Care in California Community Mental Health Centers. Am J Public Health 106:740-2
Schuck, Rachel K; Dahl, Audun; Hall, Sharon M et al. (2016) Smokers with serious mental illness and requests for nicotine replacement therapy post-hospitalisation. Tob Control 25:27-32
Guydish, Joseph; Gruber, Valerie A; Le, Thao et al. (2016) A Pilot Study of a Readiness Group to Increase Initiation of Smoking Cessation Services among Women in Residential Addiction Treatment. J Subst Abuse Treat 63:39-45
Guydish, Joseph; Tajima, Barbara; Pramod, Sowmya et al. (2016) Use of multiple tobacco products in a national sample of persons enrolled in addiction treatment. Drug Alcohol Depend 166:93-9
Kalapatapu, Raj K; Delucchi, Kevin L; Wang, Sophia et al. (2016) Substance use history in behavioral-variant frontotemporal dementia versus primary progressive aphasia. J Addict Dis 35:36-41
Barnett, Paul G; Jeffers, Abra; Smith, Mark W et al. (2016) Cost-Effectiveness of Integrating Tobacco Cessation Into Post-Traumatic Stress Disorder Treatment. Nicotine Tob Res 18:267-74
Pagano, Anna; Tajima, Barbara; Guydish, Joseph (2016) Barriers and Facilitators to Tobacco Cessation in a Nationwide Sample of Addiction Treatment Programs. J Subst Abuse Treat 67:22-9
Campbell, Barbara K; Le, Thao; Andrews, K Blakely et al. (2016) Smoking among patients in substance use disorders treatment: associations with tobacco advertising, anti-tobacco messages, and perceived health risks. Am J Drug Alcohol Abuse 42:649-656

Showing the most recent 10 out of 311 publications